The global Cancer Biomarkers Market is surging, driven by rising cancer rates, AI integration, and personalized medicine demand. Advances in genomics and liquid biopsies enhance early detection and treatment precision. More Info: https://www.imarcgroup.com/cancer-biomarkers-market